@Article{Janocha-Litwin2014,
journal="Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii",
issn="1642-395X",
volume="31",
number="6",
year="2014",
title="Case reportDRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin",
abstract="Various skin and systemic symptoms may develop as a complication of treatment with different medications and medicinal substances. One of them is a relatively rare drug reaction with eosinophilia and systemic symptoms, referred to as DRESS syndrome. The morphology of skin lesions and the patient’s general health can differ; the management involves withdrawal of drugs suspected of triggering DRESS syndrome, and administration of local and systemic glucocorticosteroids. In this paper we present a case of a patient with HCV associated chronic hepatitis, treated with peginterferon α2a (PEG-IFN-α2a) and ribavirin, who developed skin lesions and systemic symptoms typical of DRESS syndrome.",
author="Janocha-Litwin, Justyna
and Pazgan-Simon, Monika
and Simon, Krzysztof",
pages="401--404",
doi="10.5114/pdia.2014.40939",
url="http://dx.doi.org/10.5114/pdia.2014.40939"
}